| Barriers to drug delivery in solid tumors SK Sriraman, B Aryasomayajula, VP Torchilin Tissue barriers 2 (3), 2014 | 328 | 2014 |
| Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid SK Sriraman, G Salzano, C Sarisozen, V Torchilin European Journal of Pharmaceutics and Biopharmaceutics 105, 40-49, 2016 | 123 | 2016 |
| Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene delivery RR Sawant, SK Sriraman, G Navarro, S Biswas, RA Dalvi, VP Torchilin Biomaterials 33 (15), 3942-3951, 2012 | 122 | 2012 |
| Reversal of chemoresistance in ovarian cancer by co-delivery of a P-glycoprotein inhibitor and paclitaxel in a liposomal platform Y Zhang, SK Sriraman, HA Kenny, E Luther, V Torchilin, E Lengyel Molecular Cancer Therapeutics 15 (10), 2282-2293, 2016 | 75 | 2016 |
| Ceramide limits phosphatidylinositol-3-kinase C2β-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid K Kitatani, T Usui, SK Sriraman, M Toyoshima, M Ishibashi, S Shigeta, ... Oncogene 35 (21), 2801-2812, 2016 | 61 | 2016 |
| Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells SK Sriraman, J Pan, C Sarisozen, E Luther, V Torchilin Molecular pharmaceutics 13 (2), 428-437, 2016 | 56 | 2016 |
| Recent Advances with Liposomes as Drug Carriers SK Sriraman, VP Torchilin Advanced Biomaterials and Biodevices, 79-119, 2014 | 42 | 2014 |
| Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro SK Sriraman, V Geraldo, E Luther, A Degterev, V Torchilin Journal of Controlled Release 220, 160-168, 2015 | 30 | 2015 |
| Drug Delivery to the Central Nervous System SK Sriraman, G Salzano, V Torchilin Primer on Cerebrovascular Diseases (Second Edition), 198-201, 2017 | 3 | 2017 |
| Crossing the Endothelial Barrier B Aryasomayajula, SK Sriraman, VP Torchilin Drug Delivery Across Physiological Barriers, 209-238, 2016 | 1 | 2016 |
| NANOTHERANOSTICS IN GENE THERAPY M Deshpande, SK Sriraman, V Torchilin Nanotheranostics for Personalized Medicine, 191-221, 2016 | 1 | 2016 |
Vladimir TorchilinUniversity Professor, Northeastern UniversityEmail confirmado em neu.edu
